The National Leprosy Control Programme of Zimbabwe: A data analysis, 1983-1992

Leprosy Review

Volumn 69, Issue 1, 1998, Pages 46-56

  Wittenhorst, Barry ^a,b   Vree, Monika L ^a,b   Ten Ham, Peter B G ^a   Velema, Johan P ^c  

^a MINISTRY OF HEALTH AND CHILD CARE   (Zimbabwe)

^b Nijmegen Inst for Intl Health

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL FEATURE; DATA ANALYSIS; DISABILITY; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; LEPROSY; LEPROSY CONTROL; MALE; PREVALENCE; ZIMBABWE;

EID: 0031748434     PISSN: 03057518     EISSN: None     Source Type: Journal    
DOI: 10.5935/0305-7518.19980006     Document Type: Article

References (20)

1. Warndorff DK & Warndorff JA. Leprosy control in Zimbabwe: from a vertical to a horizontal programme. Lepr Rev, 1990; 61: 183-187.
2. Mudarokwa LC, ten Ham PBG. Ten years of multidrug therapy in Zimbabwe (abstract). Int. J Lep, 1993; 61: 44A.
3. Feenstra P. Needs and prospects for epidemiological tools in leprosy control. Lepr Rev, 1992; 63: Supplement, 3s-10s.
4. WHO Study Group. Chemotherapy of leprosy for control programmes. Technical Report Series No. 675, WHO, Geneva, 1982.
5. Essential drugs list for Zimbabwe 1994 - including guidelines for treatment of medical conditions common in Zimbabwe. Ministry of Health and Child Welfare, Harare, 1993.
6. WHO Expert Committee on Leprosy. Technical Report Series No. 189, WHO, Geneva, 1960.
7. Noordeen SK, Lopez Bravo L, Sundaresan TK. Estimated number of leprosy cases in the world. Lepr Rev, 1992; 63: 282-287.
8. WHO Weekly Epidemiological Record, 30 June 1995; 70: 185-188.
9. UNICEF. The state of the world's children, editions for the years 1987-1995. Oxford University Press.
10. Karonga Prevention Trial Group. Randomized controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Lancet, 348: 17-24, 1996.
11. Thet Htoon M. Indicators for use in leprosy control programmes. Lepr Rev, 1992; 63: supplement, 73s-76s.
12. Boerrigter G, Pönnighaus JM. Does the introduction of WHO-MDT influence trends in the incidence of leprosy? The Malaŵian experience. Lepr Rev, 1993; 64: 227-235.
13. WHO. Weekly Epidemiological Record, 22 September 1995; 70: 269-275.
14. Smith WCS. The epidemiology of disability in leprosy including risk factors. Lepr Rev, 1992; 63: supplement 23s-30s.
15. Irgens LM. Secular trends in leprosy: increase in age at onset associated with declining rates and long incubation periods. Int J Leprosy, 1985; 53: 610-617.
16. Noordeen SK. The epidemiology of leprosy. Medicine in the tropics. Leprosy. RC. Hastings. Churchill Livingstone, New York, 1985.
17. Pönnighaus JM, Fine PEM, Sterne JAC, Bliss L, Wilson RJ, Malema SS, Kileta S. Incidence rates of leprosy in Karonga district, northern Malawi: patterns by age, sex, BCG-status and classification. Int J Lepr, 1994; 62: 10-23.
18. McDougall AC, Pönnighaus JM, Fine PEM. Histopathological examination of skin biopsies from an epidemiological study of leprosy in northern Malawi. Int J Lepr, 1987; 55: 88-98.
19. Berhe D, Haimanot RT, Tedla T, Taddesse T. Epidemiological pattern of leprosy in Ethiopia: a review of the control programmes. Lepr Rev 1990; 61: 258-266.
20. Kharkar RD, Nagaraj K, Mane GS. Impact of multi-drug therapy on the field workers in leprosy and their future prospects (abstract). Int J Lep, 1993; 61: 57A.